Selank 10mg
Price range: 27,99 € through 31,99 €
Frequently bought together
Selank Europe Thr-Lys-Pro-Arg-Pro-Gly-Pro · Tuftsin–PGP Analogue
Selank Europe is supplied by Baltic Peptides as a lyophilised research peptide (with a research spray variant available) at ≥99% analytical purity, verified per batch by independent HPLC and mass spectrometry. Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro: the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) extended with a Pro-Gly-Pro tail that slows its breakdown.
Selank was developed in Moscow and is approved in Russia as a medicinal preparation for anxiety disorders. In research, it is studied for anxiolytic effects that do not involve direct benzodiazepine-site binding, for slowing the breakdown of enkephalins, and for effects on BDNF and immune signalling.
Supplied exclusively for in vitro and preclinical research by qualified investigators and licensed research institutions.
Third-Party Verified · COA Available · EU Dispatch
Analytical Purity
HPLC · Mass Spec Verified
Key Features
Researchers choosing Selank Europe from Baltic Peptides receive a ≥99% HPLC-verified, independently tested research peptide dispatched from within the EU.
-
Purity — ≥99% by HPLC analysis
-
Form — Lyophilised powder or research spray (select variant)
-
Storage (long-term) — −20 °C, desiccated, protected from light
-
Storage (short-term) — 2–8 °C, up to 4 weeks
-
Solubility — Sterile water, PBS or bacteriostatic water
-
Classification — Research Use Only (RUO)
-
Testing — Independent third-party batch verification
-
Documentation — Certificate of Analysis per batch
Scientific Overview — Selank Europe
Compound Background
Origin and Design
Selank was created at the Institute of Molecular Genetics of the Russian Academy of Sciences with the Zakusov Institute of Pharmacology. The design starts from tuftsin, a natural tetrapeptide cut from immunoglobulin G that activates immune cells but is degraded within minutes. Adding Pro-Gly-Pro to the C-terminus makes the peptide more resistant to peptidases while keeping tuftsin’s activity.
In rodent studies, Selank reduces anxiety-like behaviour and changes the expression of genes linked to GABAergic signalling, without the sedation, muscle relaxation or dependence seen with benzodiazepines. It also inhibits enzymes that degrade enkephalins, raises BDNF in the hippocampus, and modulates immune cytokines such as IL-6. Its approval is limited to Russia; it is not approved by the EMA or FDA.
Selank vs Semax
| Parameter | Selank | Semax |
|---|---|---|
| Parent peptide | Tuftsin (IgG fragment) | ACTH(4–7) |
| Stabilising tail | Pro-Gly-Pro | Pro-Gly-Pro |
| Main research focus | Anxiety, stress, immunity | Cognition, neuroprotection |
| Enkephalinase inhibition | Reported | Less prominent |
| Approved in Russia | Yes (anxiety) | Yes (cognitive, stroke) |
Primary Research Domains
Signalling Pathway — Research Context
Selank
GABAergic Gene Expression · Enkephalinases
↑ Enkephalins · ↑ BDNF
Reduced Anxiety-Like Behaviour
Technical Specifications — Selank Europe
| Parameter | Specification |
|---|---|
| Compound Name | Selank |
| Compound Class | Synthetic heptapeptide; tuftsin analogue |
| Sequence | H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH (TKPRPGP) |
| Molecular Formula | C33H57N11O9 |
| Molecular Weight | 751.9 g/mol |
| CAS Number | 129954-34-3 |
| Purity | ≥99% (HPLC verified per batch) |
| Forms | Lyophilised powder; research spray variant |
| Solubility | Sterile water, PBS or bacteriostatic water (≥1 mg/mL) |
| Long-Term Storage | −20 °C, desiccated, protected from light |
| Short-Term Storage | 2–8 °C, sealed vial, up to 4 weeks |
| Reconstituted Stability | Up to 14 days at 2–8 °C; avoid freeze-thaw cycling |
| Research Classification | Research Use Only (RUO) |
| Supplier | Baltic Peptides — EU dispatch from Lithuania |
Selank Europe — Lab Testing & Quality Assurance
Each batch is independently tested before release and published per lot on our COA page.
HPLC Purity Analysis
Reverse-phase HPLC confirms ≥99% purity with quantified impurity profiling.
Mass Spectrometry
ESI-MS confirms the expected 751.9 Da mass of the Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide.
Certificate of Analysis
A batch-specific COA documents purity, identity, lot number, testing dates and method references.
Third-Party Verification
Analytical data is generated by independent external laboratories for auditable, conflict-free documentation.
Storage & Handling — Selank Europe
Selank has no methionine, cysteine or tryptophan, so it is relatively resistant to oxidation. Standard cold, dry, light-protected storage applies. See our cold-chain storage guide.
Lyophilised (Unopened)
−20 °C, desiccated. Stable for 24 months from manufacture. Protect from light and moisture.
Short-Term (Unopened)
2–8 °C for up to 4 weeks in the sealed vial.
Reconstituted Solution
2–8 °C, closed and light-protected. Use within 14 days. Avoid freeze-thaw cycling. Research spray variant: keep refrigerated and use within the period stated on the label.
Reconstitution
Add solvent slowly down the vial wall and swirl gently — do not vortex. Method as in our peptide reconstitution guide.
Related Research Reading
Further reading from the Baltic Peptides Research Library:
Research Use Only — Important Notice
All products supplied by Baltic Peptides are designated exclusively for in vitro research, preclinical investigation, and laboratory study by qualified professionals operating within appropriately licensed or regulated research environments.
Selank Europe is not approved for human or veterinary use by any medicines regulator and is not intended for self-administration, clinical application, or any use outside controlled scientific research.
By completing a purchase, the buyer confirms their status as a qualified researcher and acknowledges the research-use-only classification of this compound. Baltic Peptides assumes no liability for any use beyond its stated research designation.
Frequently Asked Questions — Selank Europe
What is Selank?
Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, a stabilised analogue of tuftsin. Its formula is C33H57N11O9, molecular weight 751.9 g/mol and CAS number 129954-34-3. Baltic Peptides supplies Selank in Europe at ≥99% purity.
How does Selank differ from Semax?
Both carry the same Pro-Gly-Pro stabilising tail, but Selank is built on tuftsin and studied mainly for anxiety, stress and immune effects, while Semax is built on ACTH(4–7) and studied mainly for cognition and neuroprotection.
Does Selank act like a benzodiazepine?
Not directly. Research shows it changes GABAergic gene expression and may modulate GABA-A receptors allosterically, but it does not bind the benzodiazepine site as an agonist and has not shown sedation or dependence in animal models.
What is the role of the tuftsin core?
Tuftsin (Thr-Lys-Pro-Arg) is a natural immune-stimulating peptide. Keeping it intact gives Selank its immune-modulating activity, while the Pro-Gly-Pro tail protects it from rapid breakdown.
Is Selank approved as a medicine?
In Russia, yes — as a medicinal preparation for anxiety disorders. It is not approved in the EU, UK or US.
Is a Certificate of Analysis available for Selank Europe?
Yes. Every lot comes with a batch-specific COA documenting purity, identity, lot number and testing dates, published on the Baltic Peptides COA page.
What are the shipping conditions for Selank Europe?
Selank Europe ships from Lithuania, giving shorter transit times and no non-EU customs exposure for European researchers. Orders are packed with temperature- and light-protective materials and fully tracked. See our shipping page.







